Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

EGM Statement

30 Jun 2008 12:12

RNS Number : 8010X
Vernalis PLC
30 June 2008
 



30 June 2008

VERNALIS PLC

RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 30 JUNE 2008

Vernalis plc announces that all resolutions proposed to shareholders at the Extraordinary General Meeting held earlier today were duly passed.

All resolutions were approved on a show of hands. The number of proxy votes received for each resolution is set out below.

Resolution

For (including discretionary votes)*

Against*

Withheld

Ordinary Resolution

1. To approve the sale by the Company of Apokyn® and the US Commercial Operations

143,094,025

(99.98%)

25,322

(0.02%)

7,576

2. To increase the Company's authorised share capital and to authorise the Directors to allot relevant securities 

143,060,249

(99.98%)

28,285

(0.02%)

38,389

Special Resolution

3. To authorise the Directors to allot equity securities for cash without application of statutory pre-emption rights

142,665,007

(99.72%)

403,407

(0.28%)

58,509

*NB: Percentage of votes cast excludes withheld votes

Vernalis has forwarded to the Document Viewing Facility of the Financial Services Authority two copies of the resolutions passed at the Extraordinary General Meeting. These copies will shortly be available for viewing at the Document Facility, at the address below, from 9.00am to 5.30pm on every weekday except bank holidays.

Document Viewing Facility

The Financial Services Authority

25 The North ColonadeCanary Wharf

London E14 5HS

Tel: 020 7066 1000

Printed copies of the resolutions may be obtained by writing to The Company Secretary, Vernalis plc, Oakdene Court, 613 reading Road, Winnersh, Berkshire RG41 5UA.

Enquiries:

Vernalis plc +44 (0)118 977 3133

Tony Weir, Chief Financial Officer

Brunswick Group +44 (0)20 7404 5959

Jon Coles

Justine McIlroy

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EGMBDLLLVQBLBBQ
Date   Source Headline
31st Oct 20084:50 pmRNSSecond Price Monitoring Extn
31st Oct 20084:39 pmRNSPrice Monitoring Extension
28th Oct 200811:00 amRNSDirectorate Change
22nd Oct 20087:00 amRNSPipeline Update
21st Oct 200812:14 pmRNSHolding(s) in Company
20th Oct 20084:42 pmRNSSecond Price Monitoring Extn
20th Oct 20084:38 pmRNSPrice Monitoring Extension
17th Oct 200811:26 amRNSHolding(s) in Company
16th Oct 20084:48 pmRNSSecond Price Monitoring Extn
16th Oct 20084:38 pmRNSPrice Monitoring Extension
14th Oct 20084:52 pmRNSSecond Price Monitoring Extn
14th Oct 20084:37 pmRNSPrice Monitoring Extension
13th Oct 20084:40 pmRNSPrice Monitoring Extension
13th Oct 20087:00 amRNSResearch Update
3rd Sep 20083:52 pmRNSHolding(s) in Company
28th Aug 20087:00 amRNSInterim Results
19th Aug 20085:21 pmRNSNotice of 2008 Half Year Resu
17th Jul 20084:36 pmRNSPrice Monitoring Extension
8th Jul 20084:26 pmRNSHolding(s) in Company
7th Jul 20086:28 pmRNSHolding(s) in Company
1st Jul 20088:29 amRNSCompletion of Sale and Share
30th Jun 200812:12 pmRNSEGM Statement
26th Jun 200810:56 amRNSAnnual Information Update
26th Jun 200810:56 amRNSAGM Statement
6th Jun 20081:10 pmRNSPublication of Combined Circu
6th Jun 20081:10 pmRNS2007 ANNUAL REPORT AND ACCOUN
5th Jun 20087:00 amRNSInterim Management Statement
5th Jun 20087:00 amRNSSale of Apokyn(R) and US Comm
21st May 20084:35 pmRNSPrice Monitoring Extension
25th Apr 20087:00 amRNSPreliminary Results
21st Apr 20083:13 pmRNSNotice of Results
21st Apr 20087:04 amRNSPaul Capital Healthcare
8th Apr 20087:05 amRNSUpdate on Frova sNDA
26th Feb 20084:35 pmRNSPrice Monitoring Extension
20th Feb 20087:00 amRNSManagement Changes
20th Feb 20087:00 amRNSEndo Loan
15th Feb 20084:03 pmRNSHolding(s) in Company
30th Jan 20083:45 pmRNSHolding(s) in Company
29th Jan 200811:11 amRNSHolding(s) in Company
21st Jan 20084:10 pmRNSHolding(s) in Company
17th Jan 20082:33 pmRNSHolding(s) in Company
16th Jan 20084:43 pmRNSHolding(s) in Company
4th Jan 20083:27 pmRNSHolding(s) in Company
4th Jan 20083:26 pmRNSHolding(s) in Company
3rd Jan 20082:46 pmRNSHolding(s) in Company
21st Dec 20077:01 amRNSCita NeuroPharmaceuticals Inc
19th Dec 20074:40 pmRNSSecond Price Monitoring Extn
19th Dec 20074:35 pmRNSPrice Monitoring Extension
14th Dec 20074:35 pmRNSPrice Monitoring Extension
16th Nov 20075:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.